Article Versions Notes

Anyfanti P, Evangelidis P, Kotsiou N, Papakonstantinou A, Eftychidis I, Sakellari I, Dimitroulas T, Gavriilaki E. Chimeric Antigen Receptor T Cell Immunotherapy for Autoimmune Rheumatic Disorders: Where Are We Now? Cells. 2025; 14(16):1242. https://doi.org/10.3390/cells14161242

Anyfanti, Panagiota, Paschalis Evangelidis, Nikolaos Kotsiou, Anna Papakonstantinou, Ioannis Eftychidis, Ioanna Sakellari, Theodoros Dimitroulas, and Eleni Gavriilaki. 2025. "Chimeric Antigen Receptor T Cell Immunotherapy for Autoimmune Rheumatic Disorders: Where Are We Now?" Cells 14, no. 16: 1242. https://doi.org/10.3390/cells14161242

Anyfanti, P., Evangelidis, P., Kotsiou, N., Papakonstantinou, A., Eftychidis, I., Sakellari, I., Dimitroulas, T., & Gavriilaki, E. (2025). Chimeric Antigen Receptor T Cell Immunotherapy for Autoimmune Rheumatic Disorders: Where Are We Now? Cells, 14(16), 1242. https://doi.org/10.3390/cells14161242